QMSMEDI
QMS Medical Allied Services financials
- Market cap
- ₹287 Cr
- Sector
- Healthcare
- Calls analysed
- 4
QMS Medical Allied Services Limited Q1 FY27
What went well
- Consolidated revenues of INR 56.9 crores, up 22% YoY.
- EBITDA of INR 8.3 crores, up 27% YoY, with margin expanding to 14.6%.
- PAT of INR 4 crores, up 25% YoY.
Guidance record · Q1 FY27
what the last two calls moved 16 tracked 3 delivered 3 missed 10 open- M&A Stake Acquisition delivered said Q1 FY26 Promised: 25% by the September end, as per our agreements Q1 FY27: Status remains achieved. Management is now progressing to acquire the remaining stake to reach 100% ownership by Q2 FY27.
- Services Model Growth Rate went quiet said Q1 FY26 Promised: we need to grow by 50% every year Q1 FY27: Original 50% annual growth target remains unaddressed and appears superseded by the new FY27-specific revenue targets. Status remains ghosted.
- Total Revenue revised up said Q4 FY26 Promised: We are in line with that. There is no change in our guidance [of INR 216 crores]. Q1 FY27: Q1 revenue was ₹56.9 Cr, annualizing to ~₹228 Cr. Management slightly increased guidance to ~₹220 Cr from the previous ₹216 Cr. Status is revised_up.
All 16 tracked — every revision, and every one management stopped mentioning.
Open the guidance ledgerQuarterly results
Q1 FY27: revenue up 22.3%, net profit up 25.3% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 37 | 44 | 45 | 47 | 45 +20% | 37 −15% | 44 −0% | 57 +22% |
| EBITDA | 7 | 7 | 6 | 7 | 7 −4% | 7 −3% | 6 −7% | 8 +27% |
| Net profit | 4 | 3 | 4 | 3 | 4 −15% | 3 −9% | 2 −48% | 4 +25% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +73.1% 1Y
1Y: ₹91.25 on 10 Sept 2025 → ₹157.98. High ₹161.87 (7 Sept 2026), low ₹72 (30 Mar 2026).
How the price took the results
close before → close after
- Q1 FY27
- +4.7%
- 17 Aug
- Q4 FY26
- +3.2%
- 4 Jun
- Q2 FY26
- +0.5%
- 17 Nov
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Financials, as filed
| Year ending | FY26 |
|---|---|
| Revenue | ₹173 Cr |
| Operating profit | ₹26 Cr |
| Operating margin | 15.1% |
| Interest | ₹7 Cr |
| Depreciation | ₹4 Cr |
| Net profit | ₹12 Cr |
| Net margin | 6.8% |
| Cash from operations | ₹19 Cr |
| Free cash flow | ₹19 Cr |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Equity capital | ₹18 Cr | ₹19 Cr | ₹19 Cr |
| Reserves | ₹61 Cr | ₹86 Cr | ₹85 Cr |
| Borrowings | ₹35 Cr | ₹58 Cr | ₹68 Cr |
| Other liabilities | ₹22 Cr | ₹47 Cr | ₹41 Cr |
| Total liabilities | ₹135 Cr | ₹210 Cr | ₹213 Cr |
| Fixed assets | ₹24 Cr | ₹55 Cr | ₹57 Cr |
| Capital work in progress | ₹2 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹2 Cr | ₹1 Cr | ₹5 Cr |
| Other assets | ₹108 Cr | ₹154 Cr | ₹150 Cr |
| Total assets | ₹135 Cr | ₹210 Cr | ₹213 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, promoters trimmed −5.56 pp while the public added +3.97 pp. The shareholder count grew 4% to 1,554.
- Promoters
- 68.1%
- DIIs
- 1.6%
- Public
- 30.3%
Since Jun 2025
- Promoters −5.56 pp
- Public +3.97 pp
- DIIs +1.59 pp
How it drifted, 10 quarters
Over this window promoters fell from 73.7% to 68.1% — −5.6 pp.
Ownership split by quarter, oldest first. Dec '22: Promoters 73.7%, FIIs 0.7%, Public 25.6%.Mar '23: Promoters 73.7%, FIIs 1.2%, Public 25.1%.Sep '23: Promoters 73.7%, FIIs 1.0%, Public 25.3%.Mar '24: Promoters 73.7%, FIIs 0.0%, Public 26.3%.Sep '24: Promoters 73.7%, FIIs 0.0%, Public 26.3%.Mar '25: Promoters 73.7%, FIIs 0.0%, Public 26.3%.Jun '25: Promoters 73.7%, FIIs 0.0%, Public 26.3%.Sep '25: Promoters 68.1%, FIIs 0.0%, DIIs 1.6%, Public 30.3%.Mar '26: Promoters 68.1%, DIIs 1.6%, Public 30.3%.Jun '26: Promoters 68.1%, DIIs 1.6%, Public 30.3%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Stellar Asset Management Fund - Amrit Kaal Opportunities Fund Mutual fund newly disclosed 1.59% held
- Firm newly disclosed 0.10% held
The same filing shows 0 holders trimming and 1 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of QMS Medical Allied Services Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Mahesh Pahalraj Makhija | 66.45% | unchanged |
| Gaurang Shashikant Vasani | 3.29% | unchanged |
| Stellar Asset Management Fund - Amrit Kaal Opportunities Fund Mutual fund | 1.59% | newly disclosed |
| Diti Mahesh Makhija | 0.84% | unchanged |
| Guddi Mahesh Makhija | 0.83% | unchanged |
| Firm | 0.10% | newly disclosed |
| Amrit Kaal Opportunities Fund AIF | — | off the list |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
What the price assumes
- Growth the price implies
- 16.2% a year
- for 7 years, fading to 4%
- It has actually compounded at
- Not enough history
- The gap
- —
- between what it did and what it must do
All earnings calls (4)
Read the Q1 FY27 call →Learn to analyse QMS Medical Allied Services Limited
Guides on how to read this kind of business and the numbers that matter.